Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Entasobulin | 501921-61-5 | 98.5% | 439.89 | 50 MG
SDP

Catalog No. 5000393864
Encompass_Preferred

Entasobulin is a β-tubulin polymerization inhibitor with potential anticancer activity. It is an indolizine-glyoxylamide based small molecule that demonstrates substantial in vitro anti-proliferative activities against cancer cell lines, including multidrug resistance (MDR) phenotypes.

  • Inhibits β-tubulin polymerization
  • Shows potential anticancer activity
  • Demonstrates substantial in vitro anti-proliferative activities against cancer cell lines
  • Effective against multidrug resistance (MDR) phenotypes
  • For research use only

Catalog No. 50-003-93864 Supplier Medchemexpress LLC Supplier No. HY1677750MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Entasobulin is a β-tubulin polymerization inhibitor with potential anticancer activity. It is an indolizine-glyoxylamide based small molecule that demonstrates substantial in vitro anti-proliferative activities against cancer cell lines, including multidrug resistance (MDR) phenotypes.

  • Inhibits β-tubulin polymerization
  • Shows potential anticancer activity
  • Demonstrates substantial in vitro anti-proliferative activities against cancer cell lines
  • Effective against multidrug resistance (MDR) phenotypes
  • For research use only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.